Literature DB >> 24338704

CASP3 protein expression by flow cytometry in Down's syndrome subjects.

Michele Salemi1, Rosita A Condorelli, Corrado Romano, Barone Concetta, Carmelo Romano, Maria Grazia Salluzzo, Paolo Bosco, Aldo E Calogero.   

Abstract

Down's syndrome (DS), the most common chromosomal disorder, is caused by 21 trisomy and is featured by intellectual disability. Subjects with DS can develop some traits of Alzheimer disease (AD) at an earlier age than subjects without trisomy 21. Apoptosis is a programmed cell death process under both normal physiological and pathological conditions. Caspase-3 (CASP3) plays an important role in neuronal death during nervous system development and under certain pathological conditions. Furthermore, in vitro and in vivo studies report elevated expression and activation of CASP3 in models of AD. On this account, the expression of CASP3 gene was evaluated in cultures of fibroblasts of DS and normal subjects by flow cytometry. CASP3 protein was up-regulated in fibroblasts of DS. The data obtained from this study strengthen the hypothesis that the over-expression of CASP3 gene could have a role in the activation of the apoptotic pathways acting in the neurodegenerative processes in DS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338704     DOI: 10.1007/s13577-013-0071-x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  13 in total

1.  Apoptosis. Life and death decisions.

Authors:  Donald W Nicholson; Nancy A Thornberry
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

2.  Trisomy recurrence: a reconsideration based on North American data.

Authors:  Dorothy Warburton; Louis Dallaire; Maya Thangavelu; Lori Ross; Bruce Levin; Jennie Kline
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

3.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta.

Authors:  T Nakagawa; H Zhu; N Morishima; E Li; J Xu; B A Yankner; J Yuan
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 5.  Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.

Authors:  Graham Packham; Freda K Stevenson
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 6.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 7.  Down syndrome: advances in molecular biology and the neurosciences.

Authors:  G T Capone
Journal:  J Dev Behav Pediatr       Date:  2001-02       Impact factor: 2.225

8.  Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

Authors:  J G Sheng; R A Jones; X Q Zhou; J M McGinness; L J Van Eldik; R E Mrak; W S Griffin
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

Review 9.  Down syndrome: prenatal risk assessment and diagnosis.

Authors:  D S Newberger
Journal:  Am Fam Physician       Date:  2000-08-15       Impact factor: 3.292

10.  Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia.

Authors:  Remigio Vela-Navarrete; Marta Escribano-Burgos; Antonio López Farré; Juan García-Cardoso; Felix Manzarbeitia; Carolina Carrasco
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

View more
  1 in total

1.  Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21.

Authors:  Víctor Rodríguez-Sureda; Ángel Vilches; Olga Sánchez; Laura Audí; Carmen Domínguez
Journal:  Oxid Med Cell Longev       Date:  2015-03-17       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.